Pulmonary embolism (PE) is a potentially life-threatening condition in which a blood clot forms in the pulmonary vein carrying blood from the heart to the lungs, resulting in blood being unable to reach the lungs. Although PE can occur in anyone, it is often a complication of underlying medical problems, including deep vein thrombosis. PE is also more likely to present itself in someone who is inactive, such as someone in hospital.
The main treatment for PE is anticoagulants, a medication to prevent blood from easily clotting. LEO Pharma UK/IE understands the vital role which patient groups can have in communicating the needs of people undergoing treatment for conditions, which is why we have teamed up with AntiCoagulation UK (ACUK) to help develop a wide range of materials including a patient hub on the AntiCoagulation UK website.
The symptoms of pulmonary embolism – chest pain, shortness of breath and coughing – are very broad and can be misdiagnosed for a wide range of conditions. As a result, LEO Pharma UK/IE is committed to developing a wide range of awareness materials related to PE which go beyond treating the condition and instead look to prevent it. This disease awareness pledge emphasises our passion via our patient focus to Help SARAH and the importance of the LEO Foundation’s mission statement.